Ironwood Pharmaceuticals Announces Exercise of Over-Allotment Option in Public Offering of Common Stock

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals today announced that the underwriters of its previously announced public offering of Class A common stock have exercised their option to purchase an additional 787,500 shares.

Feed Date: 
February 13, 2012